ARTICLE | Company News
Helsinn Healthcare SA sales and marketing update
May 30, 2005 7:00 AM UTC
Helsinn's Helsinn Birex Therapeutics Ltd. unit (Dublin, Ireland) launched Aloxi palonosetron in Ireland. The selective serotonin (5-HT3) receptor antagonist is approved in Europe to prevent nausea a...